Saturday , 23 June 2018

Home » RESOURCES » INVESTING » Hologic to sell stake in blood screening unit for $1.85 bln

Hologic to sell stake in blood screening unit for $1.85 bln

Hologic Inc. rallied in Wednesday’s extended session after the company said it plans to sell its stake in a blood screening business to Grifols for $1.85 billion in cash. The divestment is expected to improve the company’s “financial flexibility,” said Hologic in a statement. The deal is scheduled to close in the first quarter. Shares of Hologic were flat in late trade after closing at $40.79 in the regular session.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Hologic to sell stake in blood screening unit for $1.85 bln Reviewed by on . Hologic Inc. rallied in Wednesday's extended session after the company said it plans to sell its stake in a blood screening business to Grifols for $1.85 billio Hologic Inc. rallied in Wednesday's extended session after the company said it plans to sell its stake in a blood screening business to Grifols for $1.85 billio Rating:
scroll to top